Cargando…

Short and long term impacts of COVID-19 on the pharmaceutical sector

BACKGROUND: The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayati, Nayyereh, Saiyarsarai, Parisa, Nikfar, Shekoufeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332346/
https://www.ncbi.nlm.nih.gov/pubmed/32617864
http://dx.doi.org/10.1007/s40199-020-00358-5
_version_ 1783553511198294016
author Ayati, Nayyereh
Saiyarsarai, Parisa
Nikfar, Shekoufeh
author_facet Ayati, Nayyereh
Saiyarsarai, Parisa
Nikfar, Shekoufeh
author_sort Ayati, Nayyereh
collection PubMed
description BACKGROUND: The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden. OBJECTIVES: Current short communication study assessed pharmaceutical market crisis during the COVID-19 era; discussing short- and long-term impacts of the pandemic on the pharmaceutical sector. RESULTS: Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels. CONCLUSION: The pandemic of COVID-19 poses considerable crisis on the health markets, including the pharmaceutical sector; and identification of these effects, may guide policy-makers towards more evidence-informed planning to overcome accompanying challenges. [Figure: see text]
format Online
Article
Text
id pubmed-7332346
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73323462020-07-06 Short and long term impacts of COVID-19 on the pharmaceutical sector Ayati, Nayyereh Saiyarsarai, Parisa Nikfar, Shekoufeh Daru Short Communication BACKGROUND: The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden. OBJECTIVES: Current short communication study assessed pharmaceutical market crisis during the COVID-19 era; discussing short- and long-term impacts of the pandemic on the pharmaceutical sector. RESULTS: Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels. CONCLUSION: The pandemic of COVID-19 poses considerable crisis on the health markets, including the pharmaceutical sector; and identification of these effects, may guide policy-makers towards more evidence-informed planning to overcome accompanying challenges. [Figure: see text] Springer International Publishing 2020-07-03 /pmc/articles/PMC7332346/ /pubmed/32617864 http://dx.doi.org/10.1007/s40199-020-00358-5 Text en © Springer Nature Switzerland AG 2020
spellingShingle Short Communication
Ayati, Nayyereh
Saiyarsarai, Parisa
Nikfar, Shekoufeh
Short and long term impacts of COVID-19 on the pharmaceutical sector
title Short and long term impacts of COVID-19 on the pharmaceutical sector
title_full Short and long term impacts of COVID-19 on the pharmaceutical sector
title_fullStr Short and long term impacts of COVID-19 on the pharmaceutical sector
title_full_unstemmed Short and long term impacts of COVID-19 on the pharmaceutical sector
title_short Short and long term impacts of COVID-19 on the pharmaceutical sector
title_sort short and long term impacts of covid-19 on the pharmaceutical sector
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332346/
https://www.ncbi.nlm.nih.gov/pubmed/32617864
http://dx.doi.org/10.1007/s40199-020-00358-5
work_keys_str_mv AT ayatinayyereh shortandlongtermimpactsofcovid19onthepharmaceuticalsector
AT saiyarsaraiparisa shortandlongtermimpactsofcovid19onthepharmaceuticalsector
AT nikfarshekoufeh shortandlongtermimpactsofcovid19onthepharmaceuticalsector